Safety and Immunogenicity of the Bris10 M2SR and Sing2016 M2SR H3N2 Monovalent Influenza Vaccines
Clinical trial NCT03999554 · COMPLETED
Trial details
- NCT number
- NCT03999554
- Sponsor
- FluGen Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-03
- Primary completion
- 2020-07-01
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.